Michael Evanisko - IQVIA Holdings Insider

Q -- USA Stock  

USD 103.48  0.57  0.55%

  Director
Mr. Michael J. Evanisko serves as Independent Director of Quintiles Transnational Holdings Inc. Mr. Evanisko is currently Chairman of PARx Solutions, Inc., a provider of processing services for physician practices, where he has served as a director and Chairman since June 2012. From September 2010 to December 2012, Mr. Evanisko served on the board of BackChannel Media, Inc. From July 2008 to May 2011, he served as a consultant to Clarion Healthcare Consulting, LLC, a strategic and organizational consulting firm to pharmaceutical, biotechnology and medical device and diagnostics businesses. From June 2002 to February 2008, Mr. Evanisko served as Executive Chairman of Adheris, Inc., a provider of educational and informational services to patients taking prescription medications. From January 2008 to June 2008, he also served as a consultant to MC Communications, LLC. He received his Bachelors degree in Labor Studies from Pennsylvania State University, his Master of Public Administration from Pennsylvania State University, his Master of Arts in Administrative Sciences from Yale University and his Master of Philosophy from Yale University. Mr. Evanisko serves as a member of the Audit Committee.
Age: 66  Director Since 2010      
919-998-2000  www.quintiles.com
Evanisko is currently Chairman of PARx Solutions, Inc., a provider of processing services for physician practices, where he has served as a director and Chairman since June 2012. From September 2010 to December 2012, Mr. Evanisko served on the board of BackChannel Media, Inc., a broadcast technology developer. From June 2002 to February 2008, Mr. Evanisko served as Executive Chairman of Adheris, Inc., a provider of educational and informational services to patients taking prescription medications. He received his Bachelor?s degree in Labor Studies from Pennsylvania State University, his Master of Public Administration from Pennsylvania State University, his Master of Arts in Administrative Sciences from Yale University and his Master of Philosophy from Yale University.

Michael Evanisko Latest Insider Activity

Management Efficiency

The company has return on total asset of 4.03 % which means that for every 100 dollars spent on asset it generated profit of $4.03. This is acceptable considering the industry classification. Similarly, it shows return on equity (ROE) of 1.89 % implying that it made 1.89 on every $100 invested by shareholders.
The company has accumulated 9.77 B in total debt with debt to equity ratio (D/E) of 130.0 implying that the company may be unable to produce cash to meet its debt commitments. IQVIA Holdings has Current Ratio of 1.2 implying that it may have difficulties to pay its interest payments when they become due.

Similar Executives

Showing few of many executives

DIRECTOR Since

William YoungVertex Pharmaceuticals Incorpor
2014
Anthony LapointeSciClone Pharmaceuticals
2009
Ronald VargoEPAM Systems
2015
Richard MayorasEPAM Systems
2013
Simon AndersonSinovac Biotech Ltd
2004
Dana CallowPAREXEL International Corporati
N/A
Richard HawkinsSciClone Pharmaceuticals
2004
Pengfei LiSinovac Biotech Ltd
2018
Fung HoiSinovac Biotech Ltd
2018
James MerselisTrinity Biotech plc
2009
Ronald AldridgePAREXEL International Corporati
2016
Linda RhodesZoetis
2017
Michael TrimbleOrigin Agritech Limited
2006
Simon LiSciClone Pharmaceuticals
2013
Patrick FortunePAREXEL International Corporati
1996
Elaine UllianVertex Pharmaceuticals Incorpor
2011
Daniel WelchSeattle Genetics
2007
Min TangOrigin Agritech Limited
2009
Yuchun LeeVertex Pharmaceuticals Incorpor
2012
Peter KuerpickEPAM Systems
2014
David StraubeEPAM Systems
2018

Entity Summary

Quintiles IMS Holdings, Inc. offer biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the AsiaPacific. IQVIA Holdings (Q) is traded on New York Stock Exchange in USA. It is located in 4820 Emperor Blvd., Durham, NC 27703, United States and employs 36,100 people.

IQVIA Holdings Leadership Team

Thomas Pike, CEO and Director
Ari Bousbib, Director
Michael Evanisko, Independent Director
Leonard Schaeffer, Independent Director
James Erlinger, Executive Vice President General Counsel, Secretary
John Danhakl, Director
Richard Staub, President - Research and Development Solutions
Michael McDonnell, CFO, Executive Vice President
Kevin Gordon, COO
John Leonard, Independent Director
James Fasano, Director
Jonathan Coslet, Director
John Connaughton, Director
Haiyuan Lo, Director
Ronald Rittenmeyer, Director
Dennis Gillings, Executive Chairman of the Board
Todd Sisitsky, Director
Jack Greenberg, Independent Director
Kevin Knightly, President - Information and Technology Solutions

Stock Performance Indicators

Current Sentiment - Q

IQVIA Holdings Investor Sentiment
More than half of Macroaxis users are at this time bullish on IQVIA Holdings. What is your judgment towards investing in IQVIA Holdings? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip
Currently Active Assets on Macroaxis
MSFT   
Purchased over 20 shares of
a day ago
Traded for 106.27
F   
Purchased over 200 shares of
a day ago
Traded for 10.56
GM   
Purchased over 70 shares of
a day ago
Traded for 39.4
GOOG   
Purchased few shares of
a day ago
Traded for 1184.91
C   
Purchased over 40 shares of
a day ago
Traded for 69.22
Additionally take a look at Your Equity Center. Please also try Money Flow Index module to determine momentum by analyzing money flow index and other technical indicators.
vendors/bower_components/jquery.easy-pie-chart/dist/jquery.easypiechart.min.js">